IMPLICATIONS OF CXCR3 EXPRESSION ON MYELOID CELLS FOR IMMUNOTHERAPY OF CANCER AND MYELOID-MEDIATED DISEASES

TOXICITY MARKER FOR 5-FLUOROURACIL

ANTI-CD3 ANTIBODIES AND METHODS OF USE

METHODS OF TREATING OR REDUCING RISK OF TRANSPLANT REJECTION

DUAL SPECIFIC ANTIBODIES

ANTIBODY COMPOSITIONS AND METHODS FOR DISRUPTING NONTUBERCULOUS MYCOBACTERIA BIOFILMS

T CELL RECEPTORS THAT BIND TO MIXED LINEAGE LEUKEMIA (MLL)-SPECIFIC PHOSPHOPEPTIDES AND METHODS OF USE THEREOF

ENGINEERED INTERLEUKIN-15 POLYPEPTIDES, COMPLEXES AND USES THEREOF

CHIMERIC CHLOROTOXIN RECEPTORS

ENDOLYSIN WITH ENHANCED ACTIVITY AGAINST BIOFILM PNEUMOCOCCI AND NASOPHARYNGEAL COLONIZATION AND METHODS THEREOF

N-ARYLPYRAZOLE NOD2 AGONISTS AS PROMOTERS OF IMMUNE CHECKPOINT INHIBITOR THERAPY

SMALL MOLECULE INHIBITORS OF KRAS PROTEINS

DIHYDROARTEMISININ DERIVATIVES AND METHODS OF MAKING AND USE THEREOF

SALT OF DIOXANE QUINOLINE COMPOUND, CRYSTAL FORM THEREOF, PREPARATION METHODS THEREFOR AND USES THEREOF

IONIZABLE LIPIDS WITH LINEAR HEAD GROUPS

IONIZABLE LIPIDS WITH BRANCHED HEAD GROUPS

VESICLES COMPRISING SECRETORY PROTEINS EXPRESSED ON THE SURFACE AND USES THEREOF FOR DELIVERY OF AN AGENT TO CELLS UNDER CELLULAR STRESS AND REGULATED CELL DEATH

TRANSDERMAL COMPOSITIONS AND METHODS OF PREPARING SAID COMPOSITIONS

ISOMERICALLY PURE BETA-CYCLODEXTRIN DERIVATIVES AND USES THEREOF

PHARMACEUTICAL COMPOSITION COMPRISING PRMT5 INHIBITOR AND PD-1/PD-L1 INHIBITOR

EXPANSION OF GAMMA DELTA T CELLS, COMPOSITIONS, AND METHODS OF USE THEREOF

HYBRID COMPOUNDS OF SCLAREOL AND DOXORUBICIN, THEIR SYNTHESIS AND APPLICATION

ISOINDOLINONE DERIVATIVE HAVING ARYLCYCLOALKYLAMIDE STRUCTURE, AND USE THEREOF

TARGETING THE m6A MRNA DEMETHYLASE FTO

METHODS OF ADJUVANT TREATMENT FOR ALLERGY IMMUNOTHERAPY

USE OF HETEROARYLOXYNAPHTHALENE COMPOUND

DEUTERATED BUPRENORPHINE AS A PROTECTIVE AGENT FOR FETAL SUBJECTS AGAINST FULL-AGONIST OPIOID EXPOSURE

Systems And Methods For Imaging Diverse Pathogenic Bacteria In Vivo With [18F]Fluoromannitol Positron Emission Tomography

COMPOSITIONS COMPRISING NEOANTIGENS AND METHODS OF ENHANCING ANTI-PD1 THERAPY

METHODS AND COMPOSITIONS FOR THE PREVENTION AND TREATMENT OF DISEASE

HYDROLYZED COLLAGEN COMPOSITIONS AND METHODS OF MAKING THE SAME

COMPOSITIONS AND METHODS FOR TISSUE REPAIR

NIGELLA SATIVA TREATMENT REGIMEN FOR CARDIAC HYPERTROPHY

COMPOSITION FOR PREVENTING, AMELIORATING, OR TREATING COGNITIVE DYSFUNCTION AND ALZHEIMER'S DISEASE COMPRISING LACTOBACILLUS FERMENTUM SRK414 STRAIN

MACROPHAGE MIGRATION INHIBITORY FACTOR (MIF) TARGETING FOR THE TREATMENT OF NON-SMALL CELL LUNG CANCER

N4-HYDROXYCYTIDINE AND DERIVATIVES AND ANTI-VIRAL USES RELATED THERETO

MITOCHONDRIA-TARGETED ATOVAQUONE: A MORE POTENT AND MORE EFFECTIVE ANTITUMOR, ANTIMICROBIAL, AND ANTIMALARIAL DRUG

MACROCYCLIC COMPOUNDS AND METHODS OF USE

METHODS FOR STABILIZING LIQUID BACTERIAL ENDOSPORE COMPOSITIONS

PHARMACEUTICAL COMPOSITION

ULOTARONT FOR TREATING ANXIETY AND ASSOCIATED CONDITIONS

ORAL PRODUCT

AEROSOL COMPOSITION

METHODS OF SELECTING CANCER PATIENTS AMENDABLE TO TREATMENT WITH IMMUNE CHECKPOINT INHIBITOR

METHODS OF TREATING INSULIN RESISTANCE AND ASSOCIATED DISORDERS

1,2,4-TRIOXANE COMPOUNDS AND COMPOSITIONS COMPRISING THE SAME FOR USE IN THE PREVENTION AND TREATMENT OF CANCER

DEVICES AND METHODS TO TREAT AND PREVENT DIVERTICULITIS

BIOMARKER FOR TYPE 1 DIABETES

Modulation of Apolipoprotein C-III (ApoCIII) Expression in Lipoprotein Lipase Deficient (LPLD) Populations

ADJUVANT FOR INTRADERMAL IMMUNIZATION AND USE THEREOF

TCR TARGETING MOLECULES AND USES THEREOF

METHODS OF TREATING A TUMOR

IL-13 ANTIBODIES FOR THE TREATMENT OF ATOPIC DERMATITIS

HUMAN BROADLY CROSSREACTIVE INFLUENZA MONOCLONAL ANTIBODIES AND METHODS OF USE THEREOF

BISPECIFIC ANTIBODY

POLYNUCLEOTIDES, POLYPEPTIDES, CELLS, AND COMPOSITIONS COMPRISING SYNTHETIC IMMUNE RECEPTORS WITH METHODS OF MANUFACTURE AND TREATMENT

Enantiomeric Compounds and Methods for Treating Invasive Tumors

IMIDAZOLONYLQUINOLINES AND THE USE THEREOF AS ATM KINASE INHIBITORS

NOVEL INDAZOLE DERIVATIVE OR PHARMACEUTICALLY ACCEPTABLE SALT THEREOF, AND USE THEREOF

BIFUNCTIONAL COMPOUNDS CONTAINING 2,5-SUBSTITUTED PYRIMIDINE DERIVATIVES FOR DEGRADING CYCLIN-DEPENDENT KINASE 2 VIA UBIQUITIN PROTEASOME PATHWAY

NOVEL PRODRUG COMPOUNDS OF 3,4-METHYLENEDIOXYMETHAMPHETAMINE (MDMA) AND METHODS OF SYNTHESIZING THE SAME

SHORT-ACTING 3,4-METHYLENEDIOXYMETHAMPHETAMINE (MDMA) ANALOGS INCORPORATING BENZOTHIAZOLE

CRYSTALLINE 5-METHOXY-N,N-DIALLYLTRYPTAMINE COMPOUNDS

GENETICALLY MODIFIED PIGS FOR XENOTRANSPLANTATION OF VASCULARIZED XENOGRAFTS AND DERIVATIVES THEREOF

FABRICATION OF CYCLODEXTRIN PARTICLES AND CRYOGELS AND METHODS OF USING AND MAKING THEREOF

DEVICES AND METHODS FOR EXTRACORPOREAL CELL TREATMENT

ANTI-VIRAL COMPOSITION AND METHOD FOR PREPARING THE SAME

PURINE COMPOUNDS FOR TREATING DISORDERS

METHOD AND APPARATUS FOR THE ACTIVE LEARNING OF A HYBRID MODEL OF A TECHNICAL SYSTEM

CRYSTAL FORM OF NK3R ANTAGONIST, AND PREPARATION METHOD THEREFOR AND USE THEREOF

NEAR-INFRARED RESPONSIVE BILIRUBIN COMPOSITE NANOPARTICLE-LOADED PERIODONTAL MICRONEEDLE AND PREPARATION METHOD THEREOF

METHOD AND DRUG FOR PROMOTING REMOVAL OF PATHOLOGICAL PROTEINS BY UBIQUITIN PROTEASOME SYSTEM AND AUTOPHAGY LYSOSOME SYSTEM

METHOD FOR PROMOTING PATHOLOGICAL TDP-43 PROTEIN DEGRADATION, AND DRUG

HUMAN AMYLIN ANALOG, AND DERIVATIVE THEREOF AND USE THEREOF

NLRP12 AND NLRC5 MODULATORS AND METHODS FOR USING THE SAME TO MODULATE DISEASES

COMPOSITIONS AND METHODS FOR THE TREATMENT OF HEMORRHAGIC SHOCK

CANNABIGEROLIC ACID (CDGA) DERIVATIVES AND USES THEREOF

METHODS AND COMPOSITIONS CONCERNING BACTEROIDES OVATUS

METHODS OF TREATMENT WITH T CELL THERAPY AND IMMUNOMODULATORY AGENT MAINTENANCE THERAPY

GOLD-CONTAINING AGENTS FOR THE TREATMENT OF LUNG INFECTIONS

MTOR THERAPEUTICS FOR CANCER

Compositions and Methods for Treatment of Fibrosis

THERAPEUTICS AND METHOD FOR TREATING OSTEOARTHRITIS

Systems and Methods for Verifying Iboga Alkaloid Treatment using Temporospatial Connectivity

STEAROYL-COA DESATURASE 1 (SCD1) INHIBITORS FOR THE TREATMENT OF HIGH-RISK MEDULLOBLASTOMA

METHODS AND SYSTEMS FOR TREATING DISEASE USING AN ATR/CHK1 SIGNALING PATHWAY INHIBITOR

SARM1 INHIBITORS FOR USE IN THERAPY AND COSMETICS

METHODS OF IDENTIFYING SENOTHERAPEUTIC TARGETS AND TREATING MUSCLE DEGRADATION

TREATMENT OF MENIERE'S DISEASE

METHOD OF PREVENTING AND/OR TREATING TISSUE DAMAGE OR INJURY

SHORT-ACTING PSYCHOACTIVE COMPOUNDS OF THE MDMA CLASS

METHODS AND COMPOSITIONS FOR TREATING SLEEP APNEA

FATTY ACID COMPOSITIONS

TREATMENT OF CENTRAL NERVOUS SYSTEM DISEASES WITH N-ACETYLCYSTEINE AND GLUCAGON-LIKE PEPTIDE-1 RECEPTOR AGONISTS

SUBSTITUTED PHENYLALKYLAMINES

REDUCING SIDE EFFECTS OF NMDA ANTAGONISTS

LIPID-POLYMER COMPOSITIONS AND METHODS OF USE

METHODS FOR ACTIVELY LOADING THERAPEUTIC MOLECULES INTO MODIFIED EXTRACELLULAR VESICLES FOR TARGETED DELIVERY TO CELLS

LIQUID CLONIDINE EXTENDED RELEASE COMPOSITION

GEL COMPOSITION, PRODUCTS CONTAINING THE SAME, AND USE THEREOF

BIODEGRADABLE FUSE-AND-RESERVOIR SYSTEM FOR THE PULSED DELIVERY OF BIOACTIVE AGENTS

THE HIPPO PATHWAY AS A PHARMACOLOGIC TARGET FOR TREATING REFRACTIVE DISORDERS

MATERIALS AND METHODS FOR MITIGATING THE PRESENCE OF NITROSAMINES IN PACKAGING USING AN ACTIVE AGENT

MICROBIOME BASED DETECTION OF ENDOMETRIOSIS

COMPOSITIONS, METHODS AND KITS FOR CHARACTERIZING AND SCREENING FOR SMALL CELL OVARIAN CARCINOMA

COMPOSITIONS AND METHODS FOR TREATMENT OF CANCERS

ANTI-CANCER TGFB2 AGENTS WITH IMMUNOTHERAPEUTICS

OLIGONUCLEOTIDES

REPROGRAMMING OF ADULT CARDIAC FIBROBLASTS INTO CARDIOMYOCYTES USING PHF7

FLT3-BINDING ANTIBODIES AND METHODS OF USE THEREOF

METHODS OF TREATING MULTIPLE MYELOMA WITH BCMA INHIBITORS IN COMBINATION WITH AN IMMUNOMODULATOR

IL-7R-alpha SPECIFIC ANTIBODIES FOR TREATING ACUTE LYMPHOBLASTIC LEUKEMIA

COMPOSITIONS AND METHODS FOR TARGETING AND KILLING ALPHA-V BETA-3 -POSITIVE CANCER STEM CELLS (CSCS) AND TREATING DRUG RESISTANT AND METASTATIC CANCERS

METHODS OF TREATING CANCER WITH A COMBINATION OF A CANCER VACCINE AND A TAAXCD28 BISPECIFIC ANTIGEN-BINDING MOLECULE

COMBINATION TREATMENT OF CHRONIC MYELOMONOCYTIC LEUKEMIA IN PATIENTS WITH RAS PATHWAY MUTATIONS

TARGETS FOR REDUCING DEMENTIA BURDEN BY TARGETING BRAIN IMAGING-BASED ENDOPHENOTYPES OF DEMENTIA

MACROCYCLIC BCL6 DEGRADERS

Aminoindane Compounds and Compositions and Methods of Their Therapeutic Use

SPLICING MODULATOR ANTIBODY-DRUG CONJUGATES AND METHODS OF USE

CARD9 VARIANT POLYPEPTIDE AND ANTIBODIES DIRECTED THERETO

METHODS OF TREATING MULTIPLE MYELOMA WITH BCMA INHIBITORS IN COMBINATION WITH LAG3 INHIBITORS

DOSING AND ADMINISTRATION OF RECOMBINANT L-ASPARAGINASE

GLP-1 RECEPTOR AGONIST

FIBROBLAST GROWTH FACTOR-21-FC FUSION PROTEINS

SILK-BASED PRODUCT FORMULATIONS AND METHODS OF USE

PEPTIDES AND METHODS OF USE THEREOF IN TREATING UVEITIS

USE OF CYCLOSPORINE ANALOGUES AS ANTITHROMBOTIC AGENTS

ENZYME FOOD FOR MAINTAINING BODY BALANCE AND PREVENTING METABOLIC SYNDROME THROUGH ENZYMES

METHODS AND COMPOSITIONS FOR TREATING INFECTIOUS, AUTOIMMUNE, AND ALLERGIC DISEASE

HUMAN-DERIVED BACTERIA THAT INDUCE PROLIFERATION OR ACCUMULATION OF REGULATORY T CELLS

COMPOSITIONS AND METHODS FOR TREATMENT OF CANCER USING BACTERIA

COMPOSITIONS AND METHODS OF TREATING LIVER DISEASE

HUMAN IFN-ALPHA2 AND PD-L1 OVEREXPRESSING T CELLS FOR IMMUNE MODULATION OF AUTOIMMUNE AND ALLOIMMUNE DISORDERS

Cell Therapeutics With Improved Persistence In Vivo And Antitumor Effect, And A Method For Producing Thereof

TREATMENT OF NEURODEGENERATIVE DISORDERS WITH DOXYCYCLINE ALONE OR IN COMBINATION WITH LEVODOPA

METHODS AND MATERIALS FOR TREATING CALCIFIC AORTIC VALVE STENOSIS

COMPOSITIONS COMPRISING BISFLUOROALKYL-1,4-BENZODIAZEPINONE COMPOUNDS FOR TREATING ADENOID CYSTIC CARCINOMA

METHODS OF ADMINISTERING VOXELOTOR

Local and Regional Anesthesia and Analgesia

COMBINED MAPK AND NAMPT INHIBITION FOR TREATMENT OF NEURON DEGENERATION

Teriflunomide Topical Pharmaceutical Compositions

DIETARY BUTYRATE

PHARMACEUTICAL COMPOSITIONS

LIPOPHILIC STATIN COMPOSITION WITH IMPROVED SOLUBILITY AND PERMEABILITY AND USES THEREOF

TOPICAL USE AND DELIVERY OF AMMONIA OXIDIZING MICROORGANISMS

SYSTEMS AND METHODS FOR VIRTUAL REALITY, AUGMENTED REALITY, AND MIXED REALITY BASED VISUAL FUNCTION ASSESSMENT

BROAD-SPECTRUM NATIONAL BIODEFENSE STRATEGY BASED UPON EPIGENETIC DEFENSE

BORRELIA BURGDORFERI PEPTIDOGLYCAN AS A DIAGNOSTIC AND TARGET FOR THERAPEUTIC INTERVENTION OF LYME DISEASE-RELATED PATHOLOGIES

A PREDICTIVE SCORE OF CANCER IMMUNOTHERAPY OUTCOME BASED ON ECOLOGICAL ANALYSIS OF GUT MICROBIOTA

METHODS OF TREATING CANCER

Trispecific T cell Engagers

ANTI-CD73 ANTIBODY AND USE THEREOF

ANTIBODIES AGAINST HUMAN CD38

RECEPTOR INHIBITION BY PHOSPHATASE RECRUITMENT

MODIFIED MULLERIAN INHIBITING SUBSTANCE (MIS) PROTEINS AND USES THEREOF FOR THE TREATMENT OF DISEASES

C-MANNOSIDE COMPOUNDS USEFUL FOR THE TREATMENT OF URINARY TRACT INFECTIONS

RAS INHIBITORS

BCL-2 INHIBITORS

CHEMOKINE RECEPTOR MODULATORS AND USES THEREOF

COMPOUNDS AND USES THEREOF

PHTHALAZINE DERIVATIVES AS PYRUVATE KINASE MODULATORS

PROTEIN KINASE C INHIBITORS AND METHODS OF THEIR USE

POLYCYCLIC COMPOUND AND USE THEREOF

MORPHOLINE-3-CARBOXAMIDE DERIVATIVES AS PROSTAGLANDIN E2 RECEPTOR 4 (EP4) AGONISTS FOR THE TREATMENT OF GASTROINTESTINAL AND PULMONARY DISEASES

LYMPH DIRECTING PRODRUGS

USE OF INTERLEUKIN-7 AND CHIMERIC ANTIGEN RECEPTOR (CAR)-BEARING IMMUNE EFFECTOR CELLS FOR TREATING TUMOR

ALTERING INFLAMMATORY STATES OF IMMUNE CELLS IN VIVO BY MODULATING CELLULAR ACTIVATION STATES

ISCHEMIA/REPERFUSION INJURY

AMMONIA OXIDIZING MICROORGANISMS FOR THE REGULATION OF BLOOD PRESSURE

LANTHANUM COMPOSITIONS FOR TREATING CANCER

COMPOSITIONS AND METHODS OF USE THEREOF

COMPOSITIONS AND METHODS OF USE THEREOF

Nucleic acid regulation of c9orf72

COMPOUNDS, COMPOSITIONS, AND METHODS

COMPOUNDS FOR REDUCING CHOLESTEROL AND TREATING LIVER AND KIDNEY DISEASE

METHODS FOR THE TREATMENT OF ABNORMAL INVOLUNTARY MOVEMENT DISORDERS

HETEROCYCLIC COMPOUNDS AND USES THEREOF

SULFUR-CONTAINING COMPOUND BASED ON GLUTARIMIDE SKELETON AND APPLICATION THEREOF

SELECTIVE ESTROGEN RECEPTOR MODULATOR FOR TREATMENT OF PANCREATIC CANCER

FUNCTIONALIZED LONG-CHAIN HYDROCARBON MONO- AND DI-CARBOXYLIC ACIDS AND DERIVATIVES THEREOF, AND THEIR USE FOR THE PREVENTION OR TREATMENT OF DISEASE

MELANOGENESIS INHIBITION COMPOSITIONS AND METHODS OF USE THEREOF

POLY(AMINE-CO-ESTER) POLYMERIC PARTICLES FOR SELECTIVE PULMONARY DELIVERY

PHARMACEUTICAL COMPOSITION AND METHOD FOR PRODUCING SAME

Method of Use, System and System Kit of Low Dose Ethyl Alcohol Enables Blood-Brain Barrier (BBB) Transient Opening

SCREENING METHOD

MULTISPECIFIC ANTIGEN-BINDING MOLECULES THAT BIND CD22 AND 4-1BB AND METHODS OF USE THEREOF

Multi Variable Domain Therapeutic Immunoglobulin

ANTI-CD79B ANTIBODIES AND IMMUNOCONJUGATES AND METHODS OF USE

METHODS FOR TREATING MYELOFIBROSIS AND RELATED CONDITIONS

TARGETING LILRB4 WITH CAR-T OR CAR-NK CELLS IN THE TREATMENT OF CANCER

CYCLIC CELL PENETRATING PEPTIDES AND METHODS OF MAKING AND USING THEREOF

MODULATORS OF 5'-NUCLEOTIDASE, ECTO AND THE USE THEREOF

BICYCLIC FERROPORTIN INHIBITORS

PEPTIDYL NITRILE COMPOUND AND USE THEREOF

METHODS FOR THE TREATMENT OR PROPHYLAXIS OF ENDOMETRIOSIS

ANTI-LRRC15 ANTIBODIES AND USES THEREOF

ANTI-TROP2/EGFR ANTIBODIES AND USES THEREOF

ANTI-NECTIN-4 ANTIBODY DRUG CONJUGATE AND USE THEREOF

ENGINEERED IGA ANTIBODIES AND METHODS OF USE

USES OF PTHRP ANALOGUE IN REDUCING FRACTURE RISK

Modulation Of Tumor Immunity By Protein-Mediated O2 Delivery

PHARMACEUTICAL COMPOSITION COMPRISING TRYPTOPHAN AND PHYLLOKININ DERIVATIVE FOR USE IN TREATING PSYCHIATRIC AND PSYCHOLOGICAL CONDITIONS

STRAIN OF BIFIDOBACTERIUM LONGUM AND USE THEREOF

METHOD FOR IMPROVING ATOPIC DERMATITIS BY USING A COMPOSITION COMPRISING LOW-MOLECULAR-WEIGHT FUCOIDAN

CANNABIDIOL COMPOSITIONS FOR USE IN THE TREATMENT OF NEURODEGENERATIVE AND NEUROLOGICAL DISORDERS

COMPOSITIONS AND METHODS FOR PREVENTING OR TREATING MUSCLE CONDITIONS

COMPOSITION COMPRISING A FIRST RAS INHIBITOR, SECOND RAS INHIBITOR AND A SHP2 INHIBITOR FOR USE IN THE TREATMENT OF CANCER

Disruption of Vascular Smooth Muscle Relaxation by Carfilzomib May be the Primary Reason for CFZ-Induced Vascular Dysfunction

METHODS OF REDUCING OR PREVENTING METASTASES

INHIBITORS OF CHYMASE FOR USE IN THE SELECTIVE RESOLUTION OF THROMBI IN THROMBOTIC OR THROMBOEMBOLIC DISORDERS

METHODS FOR THE TREATMENT OF ABNORMAL INVOLUNTARY MOVEMENT DISORDERS

REGIMENS OF ESTROGEN RECEPTOR ANTAGONISTS

Dosing Regimens for Treatment of Glioblastoma

Protein Based Soft Chew Tablets

COMPOUNDS

GDF-15 AS A DIAGNOSTIC MARKER TO PREDICT THE CLINICAL OUTCOME OF A TREATMENT WITH IMMUNE CHECKPOINT BLOCKERS

COMBINATION DRUG

PRODUCTS OF MANUFACTURE FOR THE TREATMENT, PREVENTION AND AMELIORATION OF MICROBIAL INFECTIONS

NOVEL MICROBIAL GENOTOXINS

STEM CELL BASED DELIVERY OF TUMOR-SPECIFIC RETROVIRAL VECTORS

ANTI-CANCER TGFB2 AGENTS WITH IMMUNOTHERAPEUTICS

Akkermansia muciniphila MG784 for alleviating constipation,promoting defecation, improving intestinal barrier function and intestinal immunity, and its uses

Subcutaneous Formulations Of Anti-CD38 Antibodies And Their Uses

Anti-CD38 Antibodies for Treatment of Light Chain Amyloidosis and Other CD38-Positive Hematological Malignancies

ANTI-SLC3A2-APIS ANTIGEN-BINDING PROTEINS AND METHODS OF USE THEREOF

ANTIBODIES TARGETING TIGIT AND USES THEREOF

CHIMERIC PROTEINS FOR TREATING CUTANEOUS INFLAMMATION

COMPOSITIONS INCLUDING TUMOR-BINDING GMCSF FUSION PROTEINS AND METHODS OF USING THE SAME TO TREAT SOLID TUMORS

METHODS AND COMPOSITIONS FOR TREATING METABOLIC DISORDERS

MUSCARINIC ACETYLCHOLINE M1 RECEPTOR ANTAGONISTS

Biaryl Acid Compounds

POTENT AND SELECTIVE COMPOUNDS AS SEROTONIN 1B RECEPTOR MODULATORS

MODULATORS OF THE CALCIUM SIGNALING CASCADE

POLYMERIC NANOVACCINES AND USES THEREOF

BRUSH PRODRUGS AND USES THEREOF

Methods for Treating Atopic Dermatitis by Administering an IL-4R Antagonist

Hepatitis B Virus Receptor OATP and Use Thereof

ONCOLYTIC VACCINIA VIRUSES AND RECOMBINANT VIRUSES AND METHODS OF USE THEREOF

APPLICATION OF A COMBINATION DRUG IN THE TREATMENT OF PATHOGENIC BACTERIAL PERSISTENT INFECTIONS

ENTERICALLY DELIVERED BITTER OLIGOPEPTIDES FOR THE TREATMENT FOR TYPE 2 DIABETES

PHARMACEUTICAL COMBINATION OF PRMT5 INHIBITOR AND DNA DAMAGE-INDUCING SUBSTANCE

OXAZEPINE COMPOUNDS COMPRISING A 6-AZA MOIETY AND USES THEREOF

Compositions Comprising an Inhibitor of Galectin-3

METHODS AND COMPOSITIONS FOR INHIBITION OF POLYMERASE

SOLID PHARMACEUTICAL FORMULATION OF PARP INHIBITORS AND USE THEREOF

SOLID PHARMACEUTICAL FORMULATION OF PARP INHIBITORS AND USE THEREOF

NOVEL COMPOUNDS

METHODS AND PHARMACEUTICAL COMPOSITIONS TO TREAT DRUG OVERDOSE

METHODS FOR THE TREATMENT OF ABNORMAL INVOLUNTARY MOVEMENT DISORDERS

NOVEL ENANTIOMERS OF A SERIES OF ANTIVIRAL COMPOUNDS

ADMINISTRATION OF R-BETA-HYDROXYBUTYRATE SALT BLEND AND RELATED COMPOUNDS IN HUMANS

METHODS AND COMPOSITIONS FOR TREATING GLUCOCORTICOID EXCESS

METHODS AND COMPOSITIONS FOR TREATING GLUCOCORTICOID EXCESS

METHODS AND COMPOSITIONS FOR TREATING GLUCOCORTICOID EXCESS

METHODS AND COMPOSITIONS FOR TREATING GLUCOCORTICOID EXCESS

METHODS AND COMPOSITIONS FOR TREATING GLUCOCORTICOID EXCESS

COMPOUNDS AND METHODS FOR TREATING AN EPILEPTIC DISORDER

MODULATORS OF RAR RELATED ORPHAN RECEPTORS (RORs)

COMPOSITIONS INCLUDING CAFFEIC ACID PHENETHYL ESTER

COMPOSITIONS AND METHODS USING AT LEAST ONE GLYCINE OR DERIVATIVE THEREOF AND/OR AT LEAST ONE N-ACETYLCYSTEINE OR DERIVATIVE THEREOF, AND AT LEAST ONE THYMOL AND/OR CARVACROL

COMPOSITIONS AND METHODS FOR T CELL TARGETED DELIVERY OF THERAPEUTIC AGENTS AND ACTIVATION OF T CELLS

PHARMACEUTICAL COMPOSITION AND USES THEREOF

Oral Film with Multiple Regions for Therapy of Periodontal and Dental Diseases or Disorders

TITANIA BASED GENERATORS FOR AC-225 GENERATION

Modulation of Apolipoprotein C-III (ApoCIII) Expression in Lipoprotein Lipase Deficient (LPLD) Populations

COMPOSITIONS AND METHODS FOR DELIVERY OF IMMUNE CELLS TO TREAT UN-RESECTABLE OR NON-RESECTED TUMOR CELLS AND TUMOR RELAPSE

COMPOSITIONS AND METHODS RELATED TO TUMOR ACTIVATED ANTIBODIES TARGETING PSMA AND EFFECTOR CELL ANTIGENS

ANTIBODY VARIANT COMBINATIONS AND USES THEREOF

ANTI-CCR8 MONOCLONAL ANTIBODIES AND THEIR THERAPEUTIC USE

METHODS FOR MODULATING ACTIVITY OF IL-18 FOR TREATMENT OF CD4+ T CELL MEDIATED AUTOIMMUNITY AND IMMUNOPATHOLOGY

Antagonist Antibodies Directed Against Calcitonin Gene-Related Peptide and Methods Using Same

MULLERIAN INHIBITING SUBSTANCE (MIS) PROTEINS FOR OVARIAN AND UTERINE ONCOPROTECTION, AND OVARIAN RESERVE AND UTERINE PRESERVATION

BIVALENT LECA INHIBITORS TARGETING BIOFILM FORMATION OF PSEUDOMONAS AERUGINOSA

SOLID FORMS OF AN ORALLY-DELIVERED BETA-LACTAMASE INHIBITOR AND USES THEREOF

CRYSTAL FORM OF COMPOUND AND USE THEREOF

HETEROCYCLIC INHIBITORS OF KRAS G12C MUTANT PROTEINS AND USES THEREOF

HIV INHIBITOR COMPOUNDS

IMIDAZOPIPERAZINE INHIBITORS OF TRANSCRIPTION ACTIVATING PROTEINS

Pyrazolo[5,1-f][1,2,4]triazin-4-ones as inhibitors of NOX4

MACROCYCLIC HETEROCYCLES AND USES THEREOF

INHIBITORS OF RIPK2 AND MEDICAL USES THEREOF

Alkylphenyl Substituted Compounds, Compositions and Methods of Use

COMPOUNDS AND COMPOSITIONS FOR TREATING CONDITIONS ASSOCIATED WITH STING ACTIVITY

NEODEGRADER CONJUGATES

HYALURONIC ACID BASED DRUG DELIVERY SYSTEMS

TREATMENT OF AUTOIMMUNE DISORDERS USING CHIMERIC ANTIGEN RECEPTOR THERAPY

HUMANIZED ANTI-CD40 ANTIBODIES AND USES THEREOF

INTER-ALPHA INHIBITOR PROTEINS AND METHODS OF USE THEREOF

SYNERGISTIC HERBAL COMPOSITION WITH NOOTROPIC ACTIVITY FOR IMPROVING COGNITIVE FUNCTION AND GAMING PERFORMANCE

COMPOSITION FOR USE IN THE TREATMENT AND/OR PREVENTION OF DEGENERATIVE DISEASES OF THE EYE

PHARMACEUTICAL COMPOSITION AND USE THEREOF

ENGINEERED BACTERIA AND METHODS OF USE IN TUMOR REMODELING

ENGINEERED MESENCHYMAL STEM CELL AND USE THEREOF

A METHOD OF PRODUCING EXTRACELLULAR VESICLES

PRODUCTION AND USE OF NATURAL KILLER (NK) CELL-DERIVED EXTRACELLULAR VESICLES FOR TREATMENT OF CANCER AND INFECTIOUS DISEASE

COMPOSITIONS AND METHODS OF TREATING SUBJECTS WITH BRCA1 MUTATION OR DEFICIENCY

METHODS OF TREATING CANCERS

ALKYLAMINE-CONTAINING SMALL MOLECULE DEGRADERS OF BCL6

METHODS OF ADMINISTERING A VOLTAGE-GATED POTASSIUM CHANNEL OPENER

METHOD FOR REDUCING SIDE EFFECTS FROM ADMINISTRATION OF PHOSPHODIESTERASE-4 INHIBITORS